Amlodipine plus atorvastatin is cost-effective compared to atenolol plus atorvastatin, amlodipine or atenolol alone: The Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)

被引：0

作者：

Lindgren, P. ^{[1
]}

Buxton, M. ^{[2
]}

Kahan, T. ^{[3
]}

Poulter, N. ^{[4
]}

Dahlof, B. ^{[5
]}

Sever, P. S. ^{[3
]}

Wedel, H. ^{[6
]}

Jonsson, B. ^{[7
]}

机构：

[1] European Hlth Econ, Stockholm, Sweden

[2] Brunel Univ, Uxbridge UB8 3PH, Middx, England

[3] Danderyd Hosp, Karolinska Inst, Stockholm, Sweden

[4] Univ London Imperial Coll Sci Technol & Med, London, England

[5] Sahlgrens Univ Hosp, Gothenburg, Sweden

[6] Nord Sch Publ Hlth, Gothenburg, Sweden

[7] Stockholm Sch Econ, S-11383 Stockholm, Sweden

来源：

EUROPEAN HEART JOURNAL | 2007年 / 28卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：857 / 857

页数：1

共 34 条

[31] Evaluation of C-Reactive Protein Before and On-Treatment as a Predictor of Benefit of Atorvastatin A Cohort Analysis From the Anglo-Scandinavian Cardiac Outcomes Trial Lipid-Lowering Arm
Sever, Peter S.
Poulter, Neil R.
Chang, Choon L.
Thom, Simon A. M.
Hughes, Alun D.
Welsh, Paul
Sattar, Naveed
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (08) : 717 - 729
[32] Cardiovascular event reduction in the anglo-scandinavian cardiac outcomes trial (ASCOT): Combined benefits of blood pressure reduction, lipid-lowering and treatment with a "newer" compared with an "older" antihypertensive treatment regimen
Sever, Peter
Dahlof, Bjorn
Poulter, Neil
Wedel, Hans
JOURNAL OF HYPERTENSION, 2006, 24 : 30 - 30
[33] Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesteroal concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial -: Lipid Lowering Arm (ASCOL-LLA):: a multicentre randomised controlled trial
Kübler, W
ZEITSCHRIFT FUR KARDIOLOGIE, 2003, 92 (07): : 613 - 613
[34] Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesteroal concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOL-LLA): a multicentre randomised controlled trial Peter Ssever, Björn Dahlöf, Neil R. Poulter, Hans Wedel, Gareth Beevers, Mark Caulfield, Rory Collins, Sverre Kjeldsen, Arni Kristinsson, Gordon T. McInnes, Jesper Mehlsen, Makku Nieminen, Eoin O’Brian, Jan Östergren for the ASCOT. The Lancet, published online April 2, 2003. http://image,thelancet, com/extras/03 art 3046 web.pdf. The Lancet (2003)361:1149—1158
W. Kübler
Zeitschrift für Kardiologie, 2003, 92 (7): : 613 - 613

← 1 2 3 4 →